<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>It Can Keep Cancer in Remission. Why Is No One Talking About It? — Live Feed</title><link>https://www.live-feeds.com/feed/it-can-keep-cancer-in-remission-why-is-no-one-talking-about-it</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/it-can-keep-cancer-in-remission-why-is-no-one-talking-about-it/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Exercise and Immunotherapy Drive Gains in Cancer Survival and Remission</title><link>https://www.live-feeds.com/feed/it-can-keep-cancer-in-remission-why-is-no-one-talking-about-it</link><guid isPermaLink="false">https://www.live-feeds.com/feed/it-can-keep-cancer-in-remission-why-is-no-one-talking-about-it#u129146</guid><pubDate>Sat, 17 Oct 2026 20:11:11 +0000</pubDate><description>Cancer deaths are declining as survival rates rise due to improved early detection, prevention, and targeted therapies. Recent clinical evidence highlights the role of exercise in slowing biological aging for breast cancer survivors and benefiting patients generally. Additionally, the NEOPRISM-CRC trial demonstrates that a short course of pembrolizumab immunotherapy before surgery can prevent recurrence in some patients with stage two or three bowel cancer for nearly three years. These advancements reflect a shift toward personalized oncology based on genetic alterations and immune environment</description></item>
</channel></rss>